Effects of angiotensin II and losartan in the forearm of patients with essential hypertension

被引:0
|
作者
Baan, J
Chang, PC
Vermeij, P
Pfaffendorf, M
van Zwieten, PA
机构
[1] Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Pharm, NL-2300 RC Leiden, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands
关键词
angiotensin II; losartan; hypertension; forearm blood flow;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective Angiotensin II type 1 receptor-mediated constrictor effects may be modulated by hypertension-related vascular changes, changes in receptor function and in neurohumoral activity. Design The forearm blood flow (FBF) effects of angiotensin II, methoxamine, and losartan were investigated in essential hypertensive patients. Minimal forearm vascular resistance was measured to determine structural vascular changes. Methods Seven hypertensive patients were selected, and seven matched normotensives. Angiotensin II (0.01-10 ng/kg per min) was infused during predilatation by sodium nitroprusside (6.1 +/- 0.6 ng/kg per min) before and during losartan infusion (0.3-3 mu g/kg per min). Methoxamine (0.2-2 mu g/kg per min) was co-infused with the nitric oxide synthase inhibitor N-G-monomethyl-L-arginine. FBF, measured by venous occlusion plethysmography, was expressed as the change in FBF ratio (FBFinfused arm/FBFnon-infused arm). Results Baseline FBF (infused arm) was increased by sodium nitroprusside from 2.56 +/- 0.80 to 5.46 +/- 0.92 (P< 0.05) and from 2.66 +/- 0.25 to 5.42 +/- 0.40 ml/100 ml per min (P< 0.05) in the hypertensive and normotensive group, respectively. Baseline forearm vascular resistance (FVR) was higher in the hypertensive than in the normotensive group [51 +/- 8 versus 33 +/- 3 mmHg/(ml/100 ml per min); P< 0.05]. Angiotensin II caused a maximal change in FBF ratio (E-max) by -70 +/- 3 and -72 +/- 6% in the hypertensive and normotensive group, respectively (NS). Tachyphylaxis did not occur. Infusions of losartan at 0.3, 1 and 3 mu g/kg per min reduced the E-max values from -70 +/- 3 to -50 +/- 5, -45 +/- 5 and -15 +/- 2%, respectively, in the hypertensive group, and from -72 +/- 6 to -62 +/- 4, -45 +/- 2 and -32 +/- 2%, respectively, in the normotensive group (NS). Infusion of methoxamine significantly reduced the FBF ratio by -58 +/- 6 and -69 +/- 5% in the hypertensive and normotensive groups, respectively (NS). Minimal FVR, after forearm ischemia, was the same in hypertensives and normotensives, namely 3.2 +/- 0.7 and 3.2 +/- 0.4 mmHg/(ml per 100 ml per min), respectively (NS). Conclusions Angiotensin II type 1- and alpha(1)-mediated vascular effects were unchanged by essential hypertension. Baseline FVR was greater in the hypertensives than in the normotensives, while minimal FVR was the same. These results indicate that the forearm vascular bed of the patient group studied does not show important structural and renin-angiotensin system-related functional changes as a result of hypertension. J Hypertens 16:1299-1305 (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:1299 / 1305
页数:7
相关论文
共 50 条
  • [21] Haemodynamic effects of chronic administration of Losartan, an angiotensin II receptor anatagonist, in patients with cirrhosis and portal hypertension
    Tripathi, D
    Therapondos, G
    Lui, HF
    Webb, DJ
    Hayes, PC
    JOURNAL OF HEPATOLOGY, 2002, 36 : 66 - 66
  • [22] HYPOTENSIVE EFFECT OF LOSARTAN, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN ESSENTIAL-HYPERTENSION
    TSUNODA, K
    ABE, K
    HAGINO, T
    OMATA, K
    MISAWA, S
    IMAI, Y
    YOSHINAGA, K
    AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (01) : 28 - 32
  • [23] The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension
    Smith, MC
    Barrows, S
    Meibohm, A
    Shahinfar, S
    Simpson, RL
    Weigel, K
    Dunn, MJ
    AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (12) : 1177 - 1183
  • [24] ROLE OF RENIN IN ESSENTIAL HYPERTENSION STUDIES USING ANGIOTENSIN ANTAGONISTS - ANGIOTENSIN-II BLOCKADE IN PATIENTS WITH ESSENTIAL HYPERTENSION
    ROBERTSON, JIS
    MACGREGOR, GA
    MENDELSOHN, FA
    DOYLE, AE
    NYBERG, G
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1976, 6 : 61 - 63
  • [25] Angiotensin converting enzyme genotype influences the response to the angiotensin II receptor antagonist Losartan in patients with hypertension
    Nakamura, Y
    Tamaki, S
    Uchida, Y
    Ohmichi, N
    Yamaoka, O
    Miyauchi, N
    Fukuhara, T
    Sayama, H
    Yamada, T
    Matsuo, S
    Yamada, Y
    HYPERTENSION RESEARCH, 2004, 27 (03) : 137 - 140
  • [26] ANGIOTENSIN-II BLOCKADE IN NORMALS AND PATIENTS WITH ESSENTIAL HYPERTENSION
    MACGREGOR, GA
    DAWES, PM
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1976, 6 (04) : 333 - 333
  • [27] Angiotensin-II-receptor (AT1) blockade with losartan reduces ventricular arrhythmias in essential hypertension
    Grippa, M
    Damiani, G
    Notaristefano, I
    Costa, R
    Pini, L
    Fianchini, D
    Boni, E
    Corda, L
    Chiari, E
    Zaninelli, A
    Fariello, R
    JOURNAL OF HYPERTENSION, 1998, 16 : S125 - S125
  • [28] ANGIOTENSIN-II IN ESSENTIAL HYPERTENSION
    BEEVERS, DG
    MORTON, JJ
    NELSON, CS
    PADFIELD, PL
    TITTERINGTON, M
    TREE, M
    BRITISH MEDICAL JOURNAL, 1977, 1 (6058): : 415 - 415
  • [29] Assessment of Effect of Angiotensin Ⅱ Receptor Antagonist Losartan on Aortic Distensibility in Patients With Essential Hypertension by Echocardiography
    杨好意
    邓又斌
    黎春蕾
    毕小军
    潘敏
    常青
    Journal of Huazhong University of Science and Technology(Med, 2002, (02) : 164 - 167
  • [30] Efficacy and safety of angiotensin receptor blockers: A review of losartan in essential hypertension
    Conlin, PR
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (02): : 79 - 91